The Journal of Experimental Medicine
for flow cytometry > invitrogen
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online
doi:10.1084/jem.20081461
The Journal of Experimental Medicine, Vol. 205, No. 12, 2803-2812
The Rockefeller University Press, 0022-1007 $30.00
© Watford et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 2157K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Watford, W. T.
Right arrow Articles by O'Shea, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watford, W. T.
Right arrow Articles by O'Shea, J. J.
Right arrowPubmed/NCBI databases
*Gene*GEO DataSet
*GEO Profiles*HomoloGene
*Protein*UniGene
*Substance via MeSH
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

Tpl2 kinase regulates T cell interferon-{gamma} production and host resistance to Toxoplasma gondii

Wendy T. Watford1, Bruce D. Hissong1, Lydia R. Durant1, Hidehiro Yamane2, Linda M. Muul1, Yuka Kanno1, Cristina M. Tato1, Haydeé L. Ramos1, Alan E. Berger1, Lisa Mielke1, Marko Pesu1, Benjamin Solomon1, David M. Frucht4, William E. Paul2, Alan Sher3, Dragana Jankovic3, Philip N. Tsichlis5, and John J. O'Shea1

1 Lymphocyte Cell Biology Section, Molecular Immunology and Inflammation Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892
2 Laboratory of Immunology and 3 Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892
4 Laboratory of Cell Biology, Division of Monoclonal Antibodies, Center for Drug Evaluation and Research, United States Food and Drug Administration, Bethesda, MD 20892
5 Molecular Oncology Research Institute, Tufts Medical Center, Boston, MA 02111

CORRESPONDENCE Wendy Watford: watfordw{at}mail.nih.gov

Tpl2 (Tumor progression locus 2), also known as Cot/MAP3K8, is a hematopoietically expressed serine-threonine kinase. Tpl2 is known to have critical functions in innate immunity in regulating tumor necrosis factor–{alpha}, Toll-like receptor, and G protein–coupled receptor signaling; however, our understanding of its physiological role in T cells is limited. We investigated the potential roles of Tpl2 in T cells and found that it was induced by interleukin-12 in human and mouse T cells in a Stat4-dependent manner. Deficiency of Tpl2 was associated with impaired interferon (IFN)-{gamma} production. Accordingly, Tpl2–/– mice had impaired host defense against Toxoplasma gondii with reduced parasite clearance and decreased IFN-{gamma} production. Furthermore, reconstitution of Rag2–/– mice with Tpl2-deficient T cells followed by T. gondii infection recapitulated the IFN-{gamma} defect seen in the Tpl2-deficient mice, confirming a T cell–intrinsic defect. CD4+ T cells isolated from Tpl2–/– mice showed poor induction of T-bet and failure to up-regulate Stat4 protein, which is associated with impaired TCR-dependent extracellular signal-regulated kinase activation. These data underscore the role of Tpl2 as a regulator of T helper cell lineage decisions and demonstrate that Tpl2 has an important functional role in the regulation of Th1 responses.


Abbreviations used: ChIP, chromatin immunoprecipitation; ERK, extracellular signal-regulated kinase; MAPK, mitogen-activated protein kinase; PEC, peritoneal exudate cell; siRNA, small interfering RNA; STAg, soluble T. gondii antigen.

This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jem.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS